Fortress Biotech, Inc.

FBIO · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$121-$154-$214-$165
Dep. & Amort.$4$6$9$7
Deferred Tax$0$0$0$0
Stock-Based Comp.$33$17$23$19
Change in WC-$8-$13-$1$36
Other Non-Cash$12$15$3-$14
Operating Cash Flow-$80-$128-$179-$117
Investing Activities
PP&E Inv.-$15-$0-$3-$5
Net Acquisitions$0$0-$20$57
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$2-$0-$12
Investing Cash Flow-$15-$2-$23$41
Financing Activities
Debt Repay.-$7-$39$49-$10
Stock Issued$83$80$40$155
Stock Repurch.$0$0-$1$0
Dividends Paid-$5-$9-$9-$9
Other Fin. Act.-$0-$0-$4$12
Financing Cash Flow$71$33$75$149
Forex Effect$0$0$0$0
Net Chg. in Cash-$25-$98-$127$73
Supplemental Information
Beg. Cash$83$181$308$235
End Cash$59$83$181$308
Free Cash Flow-$95-$136-$182-$133